|
Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, the results of the present study demonstrated that miR-383-5p was downregulated in LAC tissues.
|
28927114 |
2017 |
|
Adult Medulloblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we demonstrated significant downregulation of miR-383 in 23/29 (79%) MB samples and 7/7 (100%) MB cells lines.
|
23227829 |
2013 |
|
Apraxia, Developmental Verbal
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hence, this study aims to explore the function of miR-383-3p targeting IL1R2 on inflammatory injury of coronary artery endothelial cells (CAECs) in CAS.
|
29693751 |
2018 |
|
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
MicroRNA-383 is a tumor suppressor in human lung cancer, which functions to inhibit tumorigenesis of lung cancer cells both in vitro and in vivo.
|
27862077 |
2016 |
|
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Also, the susceptibility of miR-383 as a tumor marker and the relationship between its aberrant expression and clinicopathological features were determined. qRT-PCR data showed that miR-383 was dysregulated during gastric tumorigenesis.
|
28243881 |
2017 |
|
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
The present study aimed to investigate the role of miR-383-5p in gastric carcinogenesis.
|
31365693 |
2019 |
|
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
In clinical samples, miR-383 was also found to be markedly downregulated in NSCLC carcinomas than in non-carcinoma lung tissues, and in advanced-stage carcinomas than in early-stage carcinomas.
|
27551765 |
2016 |
|
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
Both microRNA-383 and EPAS1 could serve as potential therapeutic targets in the treatment of lung cancer.
|
27862077 |
2016 |
|
Carcinoma of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The expression of miR-383 was significantly decreased, and the level of Wnt1 was significantly increased (P < 0.05) in lung cancer tissues and cells.
|
30426539 |
2018 |
|
Carcinoma, Ovarian Epithelial
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
In stably miR-383-downregulated EOC cell lines, cancer proliferation, cell cycle progression, invasion and in vivo explant development were significantly suppressed.
|
27567588 |
2016 |
|
Carcinoma, Ovarian Epithelial
|
0.020 |
Biomarker
|
disease |
BEFREE |
Therefore, miR-383-5p/TRIM27 axis may be the potential target for the treatment of ovarian cancer.
|
30399596 |
2019 |
|
Cardiovascular Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
These findings highly indicate that miR-383-3p may be beneficial in the prevention of CAS and other cardiovascular diseases.
|
29693751 |
2018 |
|
cervical cancer
|
0.020 |
Biomarker
|
disease |
BEFREE |
LINC01128 expedited cells cellular process in CC by binding with miR-383-5p to release SFN.
|
31779593 |
2019 |
|
cervical cancer
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
This study demonstrates that miR-383 could down-regulate PARP2 to protect against CC by inhibiting PI3K-AKT-MTOR signaling pathway.
|
29236322 |
2018 |
|
Cervix carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
LINC01128 expedited cells cellular process in CC by binding with miR-383-5p to release SFN.
|
31779593 |
2019 |
|
Cervix carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
This study demonstrates that miR-383 could down-regulate PARP2 to protect against CC by inhibiting PI3K-AKT-MTOR signaling pathway.
|
29236322 |
2018 |
|
Childhood Medulloblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we demonstrated significant downregulation of miR-383 in 23/29 (79%) MB samples and 7/7 (100%) MB cells lines.
|
23227829 |
2013 |
|
Childhood Testicular Germ Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Abnormal testicular miR-383 expression may potentiate the connections between male infertility and testicular germ cell tumor.
|
21368870 |
2010 |
|
Cholangiocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, miR-383 serves as a tumor-suppressive miR to regulate cholangiocarcinoma cell proliferation, migration, and invasion via directly targeting IRF1.
|
30145803 |
2018 |
|
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Transfection with a miR-383 mimic suppressed proliferation and inhibited cell migration and invasion in HT-29 and LoVo colon cancer cell lines.
|
29399173 |
2018 |
|
Colon Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We observed that CREPT was up-regulated but the expression of miR-383 was down regulated in both colon cancer cell lines and colon tumor tissues.
|
29938829 |
2018 |
|
Colorectal Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
PAX6 was upregulated in CRC tissues and was negatively correlated with miR‑383 expression.
|
29512711 |
2018 |
|
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
|
29938829 |
2018 |
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Semi-quantitative real-time PCR was used to analyze the expression of miR-224 and miR-383 in 32 samples of ccRCC tumors (T) and in 32 matched control (C) samples.
|
21912701 |
2011 |
|
Diabetic Retinopathy
|
0.020 |
Biomarker
|
disease |
BEFREE |
MiR-383 was inversely correlated with AK077216 in DR patients.
|
31391356 |
2019 |